Skip to main content
Clinical Trials/NCT02820766
NCT02820766
Terminated
Not Applicable

A Non-Randomized, Prospective Study of Short Term Outcomes Following Total Knee Replacement With JOURNEY™ II BCS Total Knee System Compared to Other Posterior Stabilized Total Knee Systems in a Physical Therapy Setting

Smith & Nephew, Inc.3 sites in 1 country22 target enrollmentSeptember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
Smith & Nephew, Inc.
Enrollment
22
Locations
3
Primary Endpoint
Difference in Knee Range of Motion (ROM) at the first outpatient Physical Therapy (PT) visit (≤7 days of surgery) between the 2 treatment groups
Status
Terminated
Last Updated
8 years ago

Overview

Brief Summary

The primary objective of the study is to determine how the short-term outcome of subjects implanted with the JOURNEY™ II BCS Total Knee System compares to subjects implanted with other PS total knee systems, and to determine if there is a difference in health care resources consumed that may result in economic savings to patients, the facility and/or the payer.

To address the study objectives, patient self-assessment questionnaires, and other objective measures of post-operative function and health care resource utilization will be used for data collection.

Registry
clinicaltrials.gov
Start Date
September 2016
End Date
April 27, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Undergone unilateral primary total knee replacement with a JOURNEY™ II BCS Total Knee System or other Non-Smith \& Nephew Posterior Stabilized Knee System
  • Will be initiating outpatient PT ≤ 7 days post-operatively
  • Has a primary diagnosis of osteoarthritis, degenerative arthritis, or traumatic arthritis
  • Has pre-operative ROM ≥ 90°
  • Is skeletally mature in the PI judgment
  • Is 21 years of age of older
  • Is willing and able to participate in required follow-up visits at the study site and to complete study procedures and questionnaires
  • Has consented to participate in the study by signing the IRB/EC approved informed consent for the study
  • Agrees to follow post- operative physical therapy program

Exclusion Criteria

  • Significant preoperative varus or valgus deformities (\>15º)
  • Has received a constrained or deep dish tibial insert
  • Morbid obesity (BMI \> 40)
  • Has not obtained required pre-rehabilitation, pre-operative and intra-operative records by week 2 visit
  • Other comorbidities that may impact outcomes such as osteoporosis, uncontrolled diabetes and active infection
  • Fibromyalgia requiring treatment
  • Current or impending incarceration or is a prisoner
  • In the opinion of the PI has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, mental retardation, drug or alcohol abuse
  • Is known to be at risk for lost to follow-up, or failure to return for scheduled visits
  • Undergone or is planning to undergo total knee replacement of the contralateral knee within 6 months of this total knee replacement

Outcomes

Primary Outcomes

Difference in Knee Range of Motion (ROM) at the first outpatient Physical Therapy (PT) visit (≤7 days of surgery) between the 2 treatment groups

Time Frame: ≤7 days of surgery

The absolute Range of Motion of index knee will be compared between groups

Study Sites (3)

Loading locations...

Similar Trials